OCTAGAM normal immunoglobulin (human) 2.5g/50mL injection bottle Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 2.5g/50ml injection bottle

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: water for injections; octoxinol 10; human immunoglobulin a; tributyl phosphate; maltose - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

OCTAGAM normal immunoglobulin (human) 1g/20mL injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

octagam normal immunoglobulin (human) 1g/20ml injection vial

octapharma australia pty ltd - human immunoglobulin g, quantity: 50 mg/ml - injection - excipient ingredients: human immunoglobulin a; octoxinol 10; tributyl phosphate; maltose; water for injections - replacement therapy: primary immunodeficiency syndromes: congenital agammaglobulinaemia and hypogammaglobulinaemia; common variable immunodeficiency; severe combined immunodeficiencies; wiskott aldrich syndrome; myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections. children with congenital acquired immune deficiency syndrome (aids) who have repeated bacterial infections; immunomodulatory effect: idiopathic thrombocytopenic purpura, in adults or children with a high risk of bleeding or prior to surgery to correct platelet count. guillain barre syndrome. kawasaki disease. allogeneic bone marrow transplantation.

ALBUMIN HUMAN 20 % OCTAPHARMA SOLUTION Dél-afrikai Köztársaság - angol - South African Health Products Regulatory Authority (SAHPRA)

albumin human 20 % octapharma solution

octapharma south africa (pty) ltd - solution - see ingredients - each 1000,0 ml solution contains albumin 200,0 g

Transfer set, fluid Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

transfer set, fluid

octapharma australia pty ltd - 16610 - transfer set, fluid - a collection of items used to transfer medicines from one container to another, and then to filter the fluid medication. this is a single-use device.

Octalbin Új-Zéland - angol - Medsafe (Medicines Safety Authority)

octalbin

octapharma new zealand ltd - albumin 50 g/l;   - solution for infusion - 5 % - active: albumin 50 g/l   excipient: n-acetyl-dl-tryptophan octanoic acid potassium sodium water for injection - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated, and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

Medicine administration kit, percutaneous, non-medicated, single-use Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, non-medicated, single-use

octapharma australia pty ltd - 45158 - medicine administration kit, percutaneous, non-medicated, single-use - a collection of devices used to transfer medicines from one container to another, then to filter the fluid medication and finally for transient intravenous administration of the medicine.

Albunorm 20 Solution for injection Tanzánia - angol - Tanzania Medicinces & Medical Devices Authority

albunorm 20 solution for injection

octapharma ag., switzerland - albumin - solution for injection - 200 g/l

Nuwiq Európai Unió - angol - EMA (European Medicines Agency)

nuwiq

octapharma ab - simoctocog alfa - hemophilia a - blood coagulation factors - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).nuwiq can be used for all age groups.